Healthcare Contract Research Outsourcing Market, By Service Type (Safety Syringes (Clinical Trials (Drug Discovery, Preclinical, Phase I, Phase II, Phase III, Phase IV)), Regulatory services, Medical writing, Clinical data management, Others), By End User

Healthcare Contract Research Outsourcing Market, By Service Type (Safety Syringes (Clinical Trials (Drug Discovery, Preclinical, Phase I, Phase II, Phase III, Phase IV)), Regulatory services, Medical writing, Clinical data management, Others), By End User (CROs, Clinical Trial Laboratories, AMCs), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Healthcare Contract Research Outsourcing is conducted by pharmaceutical and medical device sectors for development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development and in the current scenario clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development is expected to propel growth of the global healthcare contract research outsourcing market over the forecast period. Furthermore, increasing number of patent expirations of leading drugs is also expected to aid in growth of the market.
Key features of the study:
This report provides in-depth analysis of the Healthcare Contract Research Outsourcing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Healthcare Contract Research Outsourcing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, IQVIA, Covance, Inc., Pharmaceutical Product Development Inc., Parexel International Corporation, Charles River Laboratories International Inc., Icon, Plc, Medidata Solutions, Inc., Inventiv Health, Inc. (Pharmanet Development Group Inc.), Medpace Holdings, Inc., and Piramal Life Sciences.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Healthcare Contract Research Outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Healthcare Contract Research Outsourcing market
Detailed Segmentation:
Healthcare Contract Research Outsourcing Market, By Service Type:
Safety Syringes
Clinical Trials
Drug Discovery
Preclinical
Phase I
Phase II
Phase III
Phase IV
Regulatory services
Medical writing
Clinical data management
Others
Healthcare Contract Research Outsourcing Market, By End User:
CROs
Clinical Trial Laboratories
AMCs
Healthcare Contract Research Outsourcing Market, By Region:
North America
By Service Type:
Clinical Trials
Drug Discovery
Preclinical
Phase I
Phase II
Phase III
Phase IV
Regulatory services
Medical writing
Clinical data management
Others
By End User
CROs
Clinical Trial Laboratories
AMCs
By Country:
U.S.
Canada
Latin America
By Service Type:
Clinical Trials
Drug Discovery
Preclinical
Phase I
Phase II
Phase III
Phase IV
Regulatory services
Medical writing
Clinical data management
Others
By End User
CROs
Clinical Trial Laboratories
AMCs
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Service Type:
Clinical Trials
Drug Discovery
Preclinical
Phase I
Phase II
Phase III
Phase IV
Regulatory services
Medical writing
Clinical data management
Others
By End User
CROs
Clinical Trial Laboratories
AMCs
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Service Type:
Clinical Trials
Drug Discovery
Preclinical
Phase I
Phase II
Phase III
Phase IV
Regulatory services
Medical writing
Clinical data management
Others
By End User
CROs
Clinical Trial Laboratories
AMCs
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Service Type:
Clinical Trials
Drug Discovery
Preclinical
Phase I
Phase II
Phase III
Phase IV
Regulatory services
Medical writing
Clinical data management
Others
By End User
CROs
Clinical Trial Laboratories
AMCs
By Country:
GCC
Israel
Rest of Middle East
Africa
By Service Type:
Clinical Trials
Drug Discovery
Preclinical
Phase I
Phase II
Phase III
Phase IV
Regulatory services
Medical writing
Clinical data management
Others
By End User
CROs
Clinical Trial Laboratories
AMCs
By Country:
South Africa
Central Africa
North Africa
Company Profiles
IQVIA *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Covance, Inc.
Pharmaceutical Product Development Inc.
Parexel International Corporation
Charles River Laboratories International Inc.
Icon, Plc
Medidata Solutions, Inc.
Inventiv Health, Inc. (Pharmanet Development Group Inc.)
Medpace Holdings, Inc.
Piramal Life Sciences
“*” marked represents similar segmentation in other categories in the respective section.